Innovations in Biomedical Computational Science and Technology Initiative (SBIR [R43/R44])

The summary for the Innovations in Biomedical Computational Science and Technology Initiative (SBIR [R43/R44]) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Innovations in Biomedical Computational Science and Technology Initiative (SBIR [R43/R44]): This funding opportunity announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose innovative research in biomedical computational science and technology to promote the progress of biomedical research. There exists an expanding need to speed the progress of biomedical research through the power of computing to manage and analyze data and to model biological processes. The NIH is interested in promoting research and developments in biomedical computational science and technology that will support rapid progress in areas of scientific opportunity in biomedical research. As defined here biomedical computing or biomedical information science and technology includes, database design, graphical interfaces, querying approaches, data retrieval, data visualization and manipulation, data integration through the development of integrated analytical tools, and tools for electronic coll! aboration, as well as computational research including the development of structural, functional, integrative, and analytical models and simulations.
Federal Grant Title: Innovations in Biomedical Computational Science and Technology Initiative (SBIR [R43/R44])
Federal Agency Name: National Institutes of Health
Grant Categories: Health Education Environment
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-06-088
Type of Funding: Grant
CFDA Numbers: 93.11493.121
CFDA Descriptions: Applied Toxicological Research and Testing 93.121 Oral Diseases and Disorders Research
Current Application Deadline: No deadline provided
Original Application Deadline: Feb 26, 2006
Posted Date: Dec 19, 2005
Creation Date: Apr 21, 2006
Archive Date: Jul 25, 2006
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: 93.172 -- Human Genome Research
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification) Small businesses
Additional Information on Eligibility
Foreign institutions are not eligible to apply. Only United States small business concerns (SBCs) are eligible to submit SBIR applications. A small business concern is one that, at the time of award for both Phase I and Phase II awards, meets all of the following criteria: 1. Is independently owned and operated, is not dominant in the field of operation in which it is proposing, has a place of business in the United States and operates primarily within the United States or makes a significant contribution to the US economy, and is organized for profit. 2. Is (a) at least 51% owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States, or (b) for SBIR only, it must be a for-profit business concern that is at least 51% owned and controlled by another for-profit business concern that is at least 51% owned and controlled by one or more individuals who are citizens of, or permanent reside! nt aliens in, the United States. 3. Has, including its affiliates, an average number of employees for the preceding 12 months not exceeding 500, and meets the other regulatory requirements found in 13 C.F.R. Part 121. Business concerns are generally considered to be affiliates of one another when either directly or indirectly, (a) one concern controls or has the power to control the other; or (b) a third-party/parties controls or has the power to control both. Control can be exercised through common ownership, common management, and contractual relationships. The term
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster